Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Begent

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Cancer Research|August 27, 1999
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agentR B Pedley, S K Sharma, G M Boxer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Secondary tumours following etoposide containing therapy for germ cell cancerC Boshoff, R H Begent, R T Oliver, et al.
British Journal of Cancer|January 1, 1991
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in manP A Philip, K D Bagshawe, F Searle, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
Quantitative distribution of 131I-labelled monoclonal antibodies administered by the intra-ventricular routeD B Smith, R P Mosely, R H Begent, et al.
British Journal of Cancer|November 1, 1996
Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragmentsJ L Casey, D J King, L C Chaplin, et al.
International Journal of Cancer|May 16, 1995
A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridomaM J Verhaar, K A Chester, P A Keep, et al.
International Journal of Cancer|April 1, 1994
Production and tumour-binding characterization of a chimeric anti-CEA Fab expressed in Escherichia coliK A Chester, L Robson, P A Keep, et al.
British Journal of Cancer|November 1, 1988
Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin AJ A Ledermann, R H Begent, K D Bagshawe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Placental site trophoblastic tumor: molecular analysis and clinical experienceM Bower, F J Paradinas, R A Fisher, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomasD B Smith, J A Ledermann, E Boesen, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Cancer Research|August 27, 1999
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agentR B Pedley, S K Sharma, G M Boxer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Secondary tumours following etoposide containing therapy for germ cell cancerC Boshoff, R H Begent, R T Oliver, et al.
British Journal of Cancer|January 1, 1991
In vivo uptake of 131I-5-iodo-2-deoxyuridine by malignant tumours in manP A Philip, K D Bagshawe, F Searle, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 1990
Quantitative distribution of 131I-labelled monoclonal antibodies administered by the intra-ventricular routeD B Smith, R P Mosely, R H Begent, et al.
British Journal of Cancer|November 1, 1996
Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragmentsJ L Casey, D J King, L C Chaplin, et al.
International Journal of Cancer|May 16, 1995
A single chain Fv derived from a filamentous phage library has distinct tumor targeting advantages over one derived from a hybridomaM J Verhaar, K A Chester, P A Keep, et al.
International Journal of Cancer|April 1, 1994
Production and tumour-binding characterization of a chimeric anti-CEA Fab expressed in Escherichia coliK A Chester, L Robson, P A Keep, et al.
British Journal of Cancer|November 1, 1988
Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin AJ A Ledermann, R H Begent, K D Bagshawe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1996
Placental site trophoblastic tumor: molecular analysis and clinical experienceM Bower, F J Paradinas, R A Fisher, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
EMOP/CA chemotherapy for the treatment of aggressive non-Hodgkin's lymphomasD B Smith, J A Ledermann, E Boesen, et al.
Pageof 17